T8	Limitation 37188 37195	Another
T10	SampleSize 35527 35548	the small sample size
T11	Limitation 35208 35210	On
T4	Limitation 36561 36568	Another
T5	OutcomeMeasures 36588 36654	the lack of objective measures monitoring the state of wakefulness
T6	Limitation 38762 38769	Another
T12	VerySpecificPopulation 38798 38826	selection bias of our sample
T13	VerySpecificPopulation 38918 38997	only participants who were medication naïve and comorbidity free were recruited
T14	Limitation 38828 38830	To
T15	Limitation 39020 39024	This
T16	Generalization 39020 39118	This makes generalization of the current findings to the “real-world” clinical settings indistinct
T17	Limitation 39230 39236	Lastly
T18	RelevantOutcomeExcluded 39427 39499	this study leaves atomoxetine effects on other brain networks unexamined
T19	Limitation 35788 35795	Several
T20	ValidityOfMeasurement 35796 35833	methodological limitations of rs-fMRI
T7	PrecisionOfMeasurement 37207 37246	he 6-minute scan lengths during rs-fMRI
T9	Limitation 38020 38025	Owing
T21	RelevantOutcomeExcluded 38058 38118	we excluded the cerebellar regions from the rs-fMRI analyses
